Heilmann will report to chief executive officer John Nicols, and will be responsible for developing the strategies and overseeing the company’s execution to grow global revenues, expand and deepen customer reach, and penetrate a widening set of industrial markets.  The company’s global business development and marketing team will report to her.

“Laurie is a highly focused, results-driven executive whose extensive experience in developing global strategies and executing on marketing objectives make her an excellent addition to Codexis as we grow our business within the pharmaceutical, food ingredients and molecular diagnostics industries, and expand into additional markets,” said Nicols. “Among her many accomplishments are expertise in building sales and marketing infrastructure, energizing and mobilizing organizational talent, and consistently exceeding annual sales goals by capitalizing on commercialization opportunities. We look forward to calling upon her vision, leadership skills and industry contacts to drive revenue growth and increase our global brand awareness. We are delighted to welcome Laurie to Codexis.”

Heilmann most recently was president of Global Life Sciences and Diagnostics at Crown Bioscience, following that firm’s acquisition in early 2018.